Study guide

6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis

Certified Burn Registered Nurse CBRN

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Introduction & Foundations of Burn Care

1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones

2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response

2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology

3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria

3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics

4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)

4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy

5 Chapter 5: Airway Management & Inhalation Injury Management

5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)

6 Chapter 6: Acute Multisystem Assessment & Critical Care Management

6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection

7 Chapter 7: Hypermetabolism & Nutritional Support

7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation

8 Chapter 8: Pain Management in Burn Care

8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction

9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus

9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients

10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings

10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances

11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure

11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management

12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy

12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion

13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries

13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy

14 Chapter 14: Special Burn Populations & Cutaneous Syndromes

14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries

15 Chapter 15: Rehabilitation, Scar Management & Reconstruction

15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management

16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage

16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response

6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis

Key Takeaways Explain This Topic AI

Major burn shock triggers intense splanchnic vasoconstriction through massive catecholamine, vasopressin, and angiotensin II release, reducing mesenteric blood flow by up to 50–60% and precipitating gut mucosal ischemia, villous atrophy, loss of tight junction integrity, and bacterial/endotoxin translocation into the portal and systemic circulation.

Paralytic ileus is nearly universal in burns >20% TBSA due to sympathetic splanchnic hyperactivity, severe electrolyte derangements (hypokalemia, hypomagnesemia), and necessary opioid analgesia; immediate gastric decompression via nasogastric (NG) or orogastric (OG) tube is essential to prevent gastric dilatation, emesis, and fatal pulmonary aspiration.

American Burn Association (ABA) Clinical Guidelines mandate initiating Early Enteral Nutrition (EEN) within 6 to 12 hours of burn injury (or as soon as resuscitation is underway); EEN preserves gut mucosal architecture, maintains tight junctions, stimulates gut-associated lymphoid tissue (GALT), reduces systemic septic complications, and blunts hypercatabolic muscle wasting.

Post-pyloric (nasojejunal) enteral feeding is strongly preferred over gastric feeding in critically ill burn patients experiencing gastroparesis, elevated gastric residual volumes, or high aspiration risk, enabling continuous, uninterrupted caloric delivery during frequent surgical debridements and operative interventions.

Curling's ulcer (acute burn stress gastroduodenopathy) is driven by severe mucosal ischemia combined with gastric acid hypersecretion; early enteral feeding represents the most potent physiological mucosal barrier defense, supplemented pharmacologically with H2-receptor antagonists (famotidine) or proton pump inhibitors (pantoprazole) during the acute critical care phase.

Last updated: August 2026

6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis

Core Knowledge: The gastrointestinal (GI) tract is often termed the "motor" of Systemic Inflammatory Response Syndrome (SIRS) and Multiple Organ Dysfunction Syndrome (MODS) in severe burn trauma. Splanchnic vasoconstriction during burn shock starves the intestinal mucosa, leading to mucosal barrier breakdown, toxic bacterial translocation, and Curling's ulcer formation. Proactive burn nursing management requires immediate GI decompression, early enteral feeding initiation within 6 to 12 hours of admission, and vigilant intra-abdominal pressure surveillance.

1. Splanchnic Hypoperfusion and Gut Barrier Breakdown

During the initial hours of burn shock, compensatory neuroendocrine mechanisms prioritize arterial perfusion to the brain and heart at the direct expense of the splanchnic circulation. PATHOPHYSIOLOGY OF THE "GUT MOTOR" OF BURN SEPSIS

  • ┌────────────────────────────────────────────────────────────────────────────────────────┐
  • │ Thermal Trauma & Hypovolemic Burn Shock (≥20% TBSA) │
  • │ │ │
  • │ ▼ │
  • │ Massive Sympathetic Adrenergic Surge ──► Epinephrine, Vasopressin & Angiotensin II │
  • │ │ │
  • │ ▼ │
  • │ Selective, Intense Splanchnic Vasoconstriction (Mesenteric Blood Flow Drops 50–60%) │
  • │ │ │
  • │ ▼ │
  • │ Ischemia of Intestinal Mucosa & Epithelial Villous Tips ──► ATP Depletion & Necrosis │
  • │ │ │
  • │ ▼ │
  • │ Disruption of Claudin / Occludin Tight Junctions ──► Hyperpermeable Gut Barrier │
  • │ │ │
  • │ ▼ │
  • │ Translocation of Intraluminal Bacteria & Endotoxin (LPS) into Mesenteric Lymphatics │
  • │ │ │
  • │ ▼ │
  • │ Activation of Gut-Associated Lymphoid Tissue (GALT) & Kupffer Cells ──► Systemic SIRS│
  • │ │ │
  • │ ▼ │
  • │ SECONDARY MULTIPLE ORGAN DYSFUNCTION SYNDROME (MODS) & LATE SEPSIS │
  • └────────────────────────────────────────────────────────────────────────────────────────┘
  • Cellular Mechanisms of Gut Barrier Failure

Ischemic Villous Tip Necrosis: The microscopic architecture of intestinal villi relies on a countercurrent microvascular exchange mechanism, rendering the tips exceptionally sensitive to hypoxia. Splanchnic hypoperfusion causes rapid sloughing of villous tip enterocytes within hours of injury.

Breakdown of Intercellular Tight Junctions: Ischemia and reactive oxygen species disrupt zonula occludens (ZO-1) and occludin protein complexes, transforming the semipermeable mucosal lining into an open, porous conduit.

Bacterial Translocation: Gram-negative enteric bacilli ( E. coli , Klebsiella ) and toxic lipopolysaccharide (LPS) endotoxins migrate directly across the compromised mucosal membrane into mesenteric lymph nodes and the portal vein, fueling persistent hyperinflammatory shock.

2. Paralytic Ileus and Gastric Decompression

Paralytic ileus is an almost universal complication in patients with burns exceeding 20% TBSA .

Pathophysiological Drivers:

Sympathetic Hyperactivity: High circulating catecholamines inhibit gastrointestinal smooth muscle motility through alpha-2 and beta-2 adrenergic activation.

Electrolyte Derangements: Hypokalemia, hypomagnesemia, and metabolic acidosis impair smooth muscle membrane depolarization.

Opioid-Induced Bowel Dysfunction: Continuous opioid infusions for severe background burn pain further paralyze enteric opioid mu-receptors. PARALYTIC ILEUS MANAGEMENT PROTOCOL

  • ┌───────────────────────────────────────────────────────────────────────────────────────┐
  • │ • Immediate Insertion of Large-Bore Nasogastric (NG) or Orogastric (OG) Tube (16–18 Fr)│
  • │ • Connect to Low Intermittent Suction (30–40 mmHg) for Immediate Decompression │
  • │ • Continuous Monitoring of Gastric Output Volume, Color, and pH │
  • │ • Serial Abdominal Exams: Palpate for Rigidity, Auscultate Bowel Sounds, Monitor Girth │
  • │ • Avoid Prolonged NPO Status: Transition to Post-Pyloric Feeding Despite Gastric Ileus │
  • └───────────────────────────────────────────────────────────────────────────────────────┘

Warning

Failure to decompress the stomach in acute burn shock leads to acute gastric dilatation, massive non-bilious or bilious vomiting, and catastrophic pulmonary aspiration. In an intubated burn patient, aspiration of acidic gastric contents triggers severe Mendelson's syndrome, necrotizing pneumonia, and refractory ARDS.

3. Early Enteral Nutrition (EEN): The Gold Standard

Modern burn critical care has replaced the historical practice of resting the gut with Early Enteral Nutrition (EEN) . BENEFITS OF EARLY ENTERAL NUTRITION (≤6–12 HOURS)

  • ┌─────────────────────────────────┬─────────────────────────────────┬─────────────────────────────────┐
  • │ MUCOSAL PRESERVATION │ METABOLIC BLUNTING │ IMMUNE ENHANCEMENT │
  • ├─────────────────────────────────┼─────────────────────────────────┼─────────────────────────────────┤
  • │ • Directly fuels enterocytes via│ • Blunts catecholamine & │ • Stimulates secretory IgA │
  • │ luminal absorption │ glucagon hypersecretion │ production from GALT │
  • │ • Preserves microvillous height │ • Reduces resting energy │ • Inhibits bacterial adherence │
  • │ • Maintains occludin tight │ expenditure (REE) surge │ to mucosal wall │
  • │ junction integrity │ • Attenuates skeletal muscle │ • Decreases bloodstream sepsis │
  • │ • Stimulates mesenteric blood │ proteolysis and nitrogen loss │ by >50% compared to TPN │
  • │ flow (postprandial hyperemia) │ • Lowers hypermetabolic core set│ • Accelerates wound healing │
  • └─────────────────────────────────┴─────────────────────────────────┴─────────────────────────────────┘
  • Clinical Implementation Guidelines

Timing: The American Burn Association (ABA) recommends initiating enteral tube feeding within 6 to 12 hours of admission (or as soon as resuscitation begins).

Starting Rate: Begin with continuous trophic feeding (e.g., 10–20 mL/hr of a high-protein, peptide-based or intact formula) and advance systematically over 24 to 48 hours to target caloric and protein goals determined by indirect calorimetry or Curreri formula.

Gastric vs. Post-Pyloric (Nasojejunal) Feeding:

Gastric Feeding: Feasible in smaller burns or hemodynamically stable patients. However, gastroparesis frequently causes elevated gastric residual volumes (GRVs) and increased aspiration risk.

Post-Pyloric / Nasojejunal (NJ) Feeding: The gold standard in severe burns (>= 30–40% TBSA). Because the small intestine retains motility and absorptive capacity even in the presence of severe gastric ileus, post-pyloric feeding permits continuous, high-volume feeding with minimal aspiration risk. Crucially, post-pyloric feeds can be safely continued intraoperatively during surgical excision and grafting , eliminating the catastrophic caloric deficits associated with repetitive "NPO after midnight" orders.

Prokinetic Pharmacotherapy: If gastric emptying is delayed, administer IV metoclopramide (10 mg IV q6h) and/or IV erythromycin (125–250 mg IV q8h) to stimulate motilin receptors and enhance gastric transit.

4. Curling's Ulcer (Acute Burn Stress Gastroduodenopathy)

First described by British surgeon Thomas Blizard Curling in 1842, Curling's ulcer refers to acute, severe stress-induced erosive gastritis and gastroduodenal ulceration occurring specifically in extensive burn trauma. PATHOGENESIS OF CURLING'S ULCER

  • ┌────────────────────────────────────────────────────────────────────────────────────────┐
  • │ Severe Thermal Burn Trauma (Splanchnic Vasoconstriction & Hypovolemia) │
  • │ │ │
  • │ ▼ │
  • │ Profound Ischemia of Gastric & Duodenal Mucosa ──► Depleted Mucosal Prostaglandins │
  • │ │ │
  • │ ▼ │
  • │ Loss of Protective Bicarbonate Mucus Barrier & Microvascular Sloughing │
  • │ │ │
  • │ ▼ │
  • │ Massive Vagal / Catecholamine Hypersecretion of Gastric Hydrochloric Acid (HCl) │
  • │ │ │
  • │ ▼ │
  • │ Acid Back-Diffusion into Denuded Submucosa ──► Deep, Solitary / Multiple Ulcerations │
  • │ │ │
  • │ ▼ │
  • │ CATASTROPHIC UPPER GI HEMORRHAGE OR DUODENAL PERFORATION │
  • └────────────────────────────────────────────────────────────────────────────────────────┘
  • Clinical Presentation and Prevention

Historically, Curling's ulcer carried a catastrophic mortality rate (>50%) from sudden, massive upper GI bleeding. In modern burn units, the incidence has dropped below 1–2% due to protocolized multimodal prophylaxis:

Prophylactic Modality Mechanism of Action Clinical Dosing & Practice Considerations

Early Enteral Nutrition (EEN) Primary physiological protectant. Direct food contact buffers luminal acid, stimulates local prostaglandin E 2 E_2 E 2 ​ synthesis, and enhances mucosal blood flow. Initiate at 10–20 mL/hr within 6–12 hours of admission; advance rapidly to goal.

Histamine-2 Receptor Antagonists (H2RAs) Competitively inhibits histamine H 2 H_2 H 2 ​ receptors on gastric parietal cells, decreasing basal and stimulated acid secretion. Famotidine: 20 mg IV/PO q12h (dose-adjusted for renal impairment / GFR).

Proton Pump Inhibitors (PPIs) Irreversibly binds and inhibits H + / K + H^+/K^+ H + / K + ATPase pumps, producing profound gastric acid suppression ( pH > 4.0 \text{pH} > 4.0 pH > 4.0 ). Pantoprazole: 40 mg IV/PO daily.; Caution: Prolonged PPI therapy increases the risk of Clostridioides difficile colitis and ventilator-associated pneumonia (VAP).

Gastric Cytoprotective Agents Binds to negatively charged proteins in ulcer beds, forming a physical paste that shields mucosa from acid and pepsin. Sucralfate: 1 g PO/NG q6h slurry. Requires gastric acid for activation; do not administer simultaneously with enteral feeds (binds formula proteins).

5. Intra-Abdominal Pressure (IAP) & Abdominal Compartment Syndrome (ACS)

During massive burn shock resuscitation (frequently associated with fluid creep exceeding > 250 mL/kg >250\text{ mL/kg} > 250 mL/kg or > 6 mL/kg / % TBSA >6\text{ mL/kg}/\%\text{TBSA} > 6 mL/kg /% TBSA ), massive crystalloid extravasation into the retroperitoneum and bowel wall causes profound visceral edema, triggering Intra-Abdominal Hypertension (IAH) and life-threatening Abdominal Compartment Syndrome (ACS) . INTRA-ABDOMINAL PRESSURE SPECTRUM & MANAGEMENT PROTOCOL

  • ┌──────────────────────┬──────────────────────┬──────────────────────────────────────────┐
  • │ Classification │ Bladder Pressure │ Clinical Actions & Nursing Management │
  • ├──────────────────────┼──────────────────────┼──────────────────────────────────────────┤
  • │ Normal Adult IAP │ 0 – 5 mmHg │ Baseline monitoring in ICU. │
  • │ ICU Post-Burn Normal │ 5 – 7 mmHg │ Common during fluid resuscitation. │
  • ├──────────────────────┼──────────────────────┼──────────────────────────────────────────┤
  • │ Intra-Abdominal │ Grade I: 12–15 mmHg │ • Initiate hourly bladder pressure checks│
  • │ Hypertension (IAH) │ Grade II: 16–20 mmHg │ • Decompress stomach (NG tube) & rectum │
  • │ │ │ • Minimize excessive crystalloids │
  • │ │ │ • Ensure adequate neuromuscular blockade │
  • ├──────────────────────┼──────────────────────┼──────────────────────────────────────────┤
  • │ Abdominal │ IAP > 20 mmHg │ • MEDICAL EMERGENCY │
  • │ Compartment │ PLUS new organ │ • Spiking peak airway pressures (>40) │
  • │ Syndrome (ACS) │ dysfunction │ • Worsening oliguria / anuria │
  • │ │ │ • Refractory shock / decreased CO │
  • │ │ │ • Emergent decompressive laparotomy │
  • └──────────────────────┴──────────────────────┴──────────────────────────────────────────┘

Bladder Pressure Transduction Technique:

Measure IAP at end-expiration in the complete supine position.

Instill exactly 20 to 25 mL of sterile saline into the bladder via a closed Foley catheter transducer system.

Zero the pressure transducer at the iliac crest in the mid-axillary line .

Calculate Abdominal Perfusion Pressure (APP) : APP = Mean Arterial Pressure (MAP) − Intra-Abdominal Pressure (IAP) \text{APP} = \text{Mean Arterial Pressure (MAP)} - \text{Intra-Abdominal Pressure (IAP)} APP = Mean Arterial Pressure (MAP) − Intra-Abdominal Pressure (IAP)

Clinical Goal: Maintain APP ≥ 60 mmHg \text{APP} \ge 60\text{ mmHg} APP ≥ 60 mmHg to ensure adequate mesenteric and renal cortical blood flow.